openPR Logo
Press release

Mesothelioma Treatment Tomudex Receives International Support

10-28-2010 08:45 AM CET | Politics, Law & Society

Press release from: Weitz & Luxenberg

Leading Personal Injury Law Firm

Leading Personal Injury Law Firm

Mesothelioma treatment Tomudex, made by a global pharmaceutical company, is receiving approval from a panel of international experts. Tomudex falls in the group of anti-cancer drugs known as antineoplastics. It prevents cell growth. By doing so, it leads to the elimination of tumors.

In a study examining people diagnosed with pleural mesothelioma, the use of Tomudex in conjunction with Platinol resulted in improved response rates of 23.6% as opposed to 13.6% for those using Platinol alone. Secondly, 58% of those who received Tomudex and Platinol in their mesothelioma treatment program showed no new growth of mesothelioma tumor whereas 54% of those who received Platinol only showed no new growth. Finally, the median-survival rate of those who received Tomudex and Platinol was 11.4 months whereas the survival rate for those who received Platnol only was 8.8 months. Tomudex has not yet received FDA approval.

Malignant pleural mesothelioma is an asbestos cancer that develops in the lining of the lungs (the pleura). It is the most common form of mesothelioma. Other types of mesothelioma are peritoneal mesothelioma and pericardial mesothelioma. Pleural mesothelioma develops decades after exposure to asbestos fibers. Asbestos exposure occurs when airborne asbestos fibers are inhaled. Inhaled asbestos fibers become trapped in the lungs and eventually, lead to malignant mesothelioma. Mesothelioma symptoms associated with pleural mesothelioma are shortness of breath, chest pan, coughing of blood, fatigue and night sweats.

Mesothelioma treatment approaches aim to provide relief from symptoms of the cancer because there is no cure. Treatment techniques include chemotherapy, surgery and radiation therapy and photodynamic therapy (PDT). Mesothelioma disease claims the lives of about 3,000 people in the U.S. every year. People who worked with asbestos-containing products are at highest risk of developing mesothelioma. This includes mechanics, sheet metal workers, construction workers, electricians and plumbers.

This press release was prepared by the law firm of Weitz & Luxenberg. Weitz & Luxenberg is a law firm that specializes in providing legal services to those who have been diagnosed with asbestos cancers such as lung cancer and malignant mesothelioma. Weitz & Luxenberg provides free information on jobs involving the risk of mesothelioma at www.mesotheliomajobs.com. For information on legal services provided by Weitz & Luxenberg mesothelioma attorneys, visit
http://www.weitzlux.com/mesothelioma-attorney_1932416.html

For more information on mesothelioma cancer, visit: www.yourmesotheliomaweb.com.

Weitz & Luxenberg
700 Broadway 3rd floor
New York, NY 10003

Media contact:
Jason Wentworth
hkader@weitzlux.com
1-800-438-9786 ext. 5645

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mesothelioma Treatment Tomudex Receives International Support here

News-ID: 149463 • Views: 3006

More Releases from Weitz & Luxenberg

Weitz & Luxenberg Cited for Top NYS 2014 Product Liability Cases by New York Law …
Weitz & Luxenberg, P.C. has been recognized by the New York Law Journal for winning the top three product liability verdicts in New York State in 2014. “The lawyers and law firms who are ranked in this special section represent the best of the best in 2014,” New York Law Journal associate publisher Farrell McManus wrote in the Journal’s “Top Verdicts New York 2014.” He continued, “Their zealous advocacy on
New Mesothelioma Treatment Technique Developed
Extrapleural pneumonectomy, a surgical procedure that removes mesothelioma cancer from the lining of the lung, has been reported to be an effective new mesothelioma treatment technique. The technique was developed by Dr. Sugarbaker, the co-leader of the Brigham Biomedical Research Institute's Cancer Research Center, Chief of the Institute's Division of Thoracic Surgery and a Professor of Oncologic Surgery at Harvard Medical School. The surgical technique was applied on a mesothelioma patient
Mesothelioma Cancer: Possible Treatment Option
An experiment carried out in Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and the Medical University Vienna has tested the effectiveness of a genetically modified virus to treat mesothelioma in animals. The virus is known as Newcastle Disease Virus (NDV). Animals with mesothelioma administered with multiple doses of NDV responded better than those that received a single dose. The use of a genetically engineered virus to disrupt the function
Asbestos Cancer Mesothelioma Afflicts a 39 Year Old Woman
It has been reported that a 39 year old woman has been diagnosed with the cancer mesothelioma. This is somewhat unusual because mesothelioma most frequently afflicts people who are much older. Mesothelioma is caused by exposure to the deadly mineral, asbestos. Asbestos exposure is known to cause various types of malignant mesothelioma. These include lung mesothelioma (or pleural mesothelioma) and abdominal mesothelioma (or peritoneal mesothelioma). Mesothelioma causing asbestos was used

All 5 Releases